European Archives - Page 365 of 1010 - European Medical Journal

Editor’s Pick: Impact of COVID-19 on Diagnostic Delay in Rare Disease

Rare diseases are individually rare but collectively common, with a combined prevalence of 3.5–5.9%. A common feature of many diseases is a substantial delay in patients receiving a correct diagnosis; this protracted path to diagnosis is termed ‘the diagnostic odyssey’.

Key Insights from EULAR 2022: An Interdisciplinary Expert Roundtable Discussion

IME Rheumatology Webinar | Key Insights from EULAR 2022 - An Interdisciplinary Expert Roundtable Discussion

Watch our roundtable discussion to gain a deeper understanding of emerging data from the EULAR 2022 congress.

New AZ study reveals extent of CKD worldwide

Chronic kidney disease is present in one in 10 adults, according to a recent study by AstraZeneca. Read the article for more details.

EMJ Cardiology 10 [Supplement 2] 2022 Feature Image

Novel Targeted Compression for the Prevention of Implantable Cardioverter Defibrillator or Pacemaker Pocket Complications: Strategies to Avoid Haematoma and Minimise Risk of Infection

Implantable cardioverter defibrillators (ICDs), pacemakers, and cardiac resynchronisation therapy (CRT) devices are placed in a pocket…

EMJ Cardiology 10 [Supplement 2] 2022 Feature Image

EMJ Cardiology 10 [Supplement 2] 2022

EMJ had the pleasure of interviewing leading specialists within the field of cardiology and electrophysiology, Bruno Schwagten, ZNA Middelheim, Antwerp, Belgium, and Yurii Deminskyi…

Cardiovascular catalyst launched by Novartis

A new CVD initiative has been launched by Novartis UK to drive innovation and improve patient access to prevention solutions.

Big pharma vs biotech and the future of marketing

Helena and Marc are joined by Michele Manto, CCO, Galapagos, and Robert Grimm, Digital Marketing and Transformation Manager, Novo Nordisk.

EMJ

EMJ ranked as one of Britain's fastest-growing private companies

EMJ, Europe’s leading digital health communications company, has been ranked in the 2022 edition of The Sunday Times 100.

Sanofi set to slash insulin costs in US

Sanofi is set to cut the pricing of its insulin products in a massive step toward greater access to medicine in the US. Read to find out more.

Genomic Profiling of Breast Cancer: A Multidisciplinary approach in early stage breast cancer treatment decisions

A virtual webinar presentation featuring Dr. Cathy Graham & Dr. William Audeh exploring latest data and impact of MammaPrint®️ and BluePrint®️